Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Operating Expenses (2016 - 2025)

Ironwood Pharmaceuticals' Other Operating Expenses history spans 13 years, with the latest figure at -$252000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 445.21% year-over-year to -$252000.0; the TTM value through Dec 2025 reached $20.3 million, up 681.22%, while the annual FY2025 figure was $20.3 million, 681.22% up from the prior year.
  • Other Operating Expenses for Q4 2025 was -$252000.0 at Ironwood Pharmaceuticals, down from $2.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.1 billion in Q2 2023 and bottomed at -$252000.0 in Q4 2025.
  • The 3-year median for Other Operating Expenses is $2.1 million (2024), against an average of $105.9 million.
  • The largest YoY upside for Other Operating Expenses was 13650.0% in 2025 against a maximum downside of 445.21% in 2025.
  • A 3-year view of Other Operating Expenses shows it stood at $5.6 million in 2023, then crashed by 98.7% to $73000.0 in 2024, then crashed by 445.21% to -$252000.0 in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Other Operating Expenses are -$252000.0 (Q4 2025), $2.2 million (Q3 2025), and -$250000.0 (Q2 2025).